LPL Financial
PRCT icon

LPL Financial’s Procept Biorobotics PRCT Stock Holding History

LPL Financial’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Buy
11,828
+1,842
+18% +$46.1K ﹤0.01% 5544
2026
Q1 		$250K Buy
9,986
+1,119
+13% +$31.5K ﹤0.01% 5330
2025
Q4 		$279K Buy
8,867
+1,356
+18% +$45K ﹤0.01% 5201
2025
Q3 		$268K Buy
7,511
+1,161
+18% +$53K ﹤0.01% 5139
2025
Q2 		$366K Sell
6,350
-1,257
-17% -$71.1K ﹤0.01% 4628
2025
Q1 		$443K Sell
7,607
-1,834
-19% -$125K ﹤0.01% 4283
2024
Q4 		$760K Buy
9,441
+4,157
+79% +$355K ﹤0.01% 3726
2024
Q3 		$423K Buy
+5,284
New +$375K ﹤0.01% 4137

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LPL Financial's PRCT Position: Q2 2026 in Review

LPL Financial increased its Procept Biorobotics (PRCT) stake by 18% in Q2 2026, buying an estimated $46.1K and bringing the position to 11,828 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #5544.

LPL Financial first reported a position in PRCT in Q3 2024 and has held it in 8 quarters since. The position peaked at $760K in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • LPL Financial held 11,828 shares of Procept Biorobotics worth $267K as of Q2 2026.
  • LPL Financial bought 1,842 Procept Biorobotics shares in Q2 2026, an estimated $46.1K.
  • Procept Biorobotics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5544 holding.
  • LPL Financial first reported a position in Procept Biorobotics in Q3 2024 and has held it in 8 quarters since.
  • LPL Financial's Procept Biorobotics position peaked at $760K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.